Inhibitory effects of central hypertensive activity of angiotensin I and II by 1-sar-8-ala-angiotensin II (saralasin acetate).
D000109:Acetylcholine / Q000494:pharmacology; D000409:Alanine / Q000008:administration & dosage / Q000494:pharmacology; D000704:Analysis of Variance; D000804:Angiotensin II / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002339:Carotid Arteries / Q000502:physiology; D002415:Cats; D002552:Cerebral Ventricles; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D010477:Perfusion; D012521:Sarcosine / Q000008:administration & dosage / Q000494:pharmacology; D013997:Time Factors
D000804:Angiotensin II; D000109:Acetylcholine; D000409:Alanine; D004837:Epinephrine; D012521:Sarcosine